Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New method could improve outcome of leukemia patients receiving stem-cell transplants

New method could improve outcome of leukemia patients receiving stem-cell transplants

Using molecular targeting approach to kill melanoma cells

Using molecular targeting approach to kill melanoma cells

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

FDA approves new treatment for AML patients

FDA approves new treatment for AML patients

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Study uncovers new mechanism controlling the master cancer regulator

Study uncovers new mechanism controlling the master cancer regulator

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

St. Jude Hospital announces availability of largest collections of leukemia samples

St. Jude Hospital announces availability of largest collections of leukemia samples

Researchers unravel mystery of NPM1 protein in acute myeloid leukemia

Researchers unravel mystery of NPM1 protein in acute myeloid leukemia

Cancer stem cells depend on amino acid metabolism, and it's proving to be their Achilles' heel

Cancer stem cells depend on amino acid metabolism, and it's proving to be their Achilles' heel

New study sheds light on how CAR T cell therapy works

New study sheds light on how CAR T cell therapy works

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Researchers develop first chemical inhibitors for treatment of acute myeloid leukemia

Researchers develop first chemical inhibitors for treatment of acute myeloid leukemia

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

PPM1D gene confers a survival advantage to stem cells after chemotherapy

PPM1D gene confers a survival advantage to stem cells after chemotherapy

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

Measles can be deadly for people with weakened immune systems

Measles can be deadly for people with weakened immune systems

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.